-
Status epilepticus, in the setting of cancer, is treatable and does not appear to increase mortality above the risk of the underlying disease.
-
This article reports a strong correlation between abnormal MRI at term equivalent in preterm infants with adverse neurodevelopmental outcomes at 2 years of age, suggesting its utility for risk stratification.
-
This case series describes clinical features and treatment responses of an unusual focal leg action dystonia in 5 long distance runners.
-
Lipoprotein(a) is a low density lipoprotein that is implicated in atherosclerotic cerebrovascular disease. Elevated levels of Lp(a) appear to confer an increased risk of ischemic stroke.
-
Faster progression of ALS is predicted by older age, presentation with bulbar signs, or presentation with distal limb muscle weakness.
-
Vitamin D supplementation may lower the risk of developing multiple sclerosis.
-
Aggressive statin therapy is associated with slowed progression and even regression of atherosclerosis. A new study suggests that, when monitoring statin therapy, increases in HDL cholesterol may be as important as decreases in LDL cholesterol in preventing disease progression.
-
-
-
Until now, there has been no proven therapy for nonalcoholic steatohepatitis. Pioglitazone, known to improve insulin resistance, was shown to result in metabolic and histologic improvement in this common and potentially highly morbid malady.
